# Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer

> **NCT01965522** · PHASE2 · COMPLETED · sponsor: **Juravinski Cancer Center** · enrollment: 100 (actual)

## Conditions studied

- Early Stage Breast Cancer

## Interventions

- **DRUG:** Melatonin
- **DRUG:** Vitamin D
- **DRUG:** Placebo (melatonin)
- **DRUG:** Placebo (vitamin D)

## Key facts

- **NCT ID:** NCT01965522
- **Lead sponsor:** Juravinski Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2016-08
- **Final completion:** 2017-05
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2017-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01965522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01965522, "Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01965522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*